Artificial intelligence (AI) and machine learning (ML) technologies are increasingly integrated into clinical research and healthcare delivery. While these tools promise improved diagnostic precision, operational efficiency, and personalized interventions, they introduce profound ethical, regulatory, and equity-related challenges.

This study develops a comprehensive conceptual framework for the responsible integration of AI/ML in clinical research and care, emphasizing interpretability, governance, reporting standards, workforce diversity, participant engagement, and health equity.

A structured narrative synthesis was conducted using foundational scholarship on clinical ML applications, responsible AI frameworks, AI-specific reporting guidelines, regulatory proposals, stakeholder engagement models, and diversity initiatives within biomedical research. Theoretical constructs were integrated across ethical, clinical, regulatory, and sociotechnical domains to produce an implementation-oriented analytical framework.

Responsible AI in clinical contexts requires multidimensional alignment across five domains: algorithmic transparency and interpretability; regulatory adaptability; rigorous reporting and evaluation standards; participant-centered engagement and health literacy; and systemic investment in workforce diversity. The analysis demonstrates that technical robustness alone is insufficient for trustworthy deployment. Instead, trust emerges from transparent validation, participatory governance, equitable representation in data and research teams, and ethically grounded clinical decision support integration.

AI-enabled clinical research and care must be governed by principles that extend beyond computational performance. Regulatory innovation, structured reporting, stakeholder-centric engagement, and diversification of the biomedical workforce are mutually reinforcing pillars of responsible AI ecosystems. Sustainable implementation demands systemic transformation rather than incremental technological adoption.